Company: CMND
Filing Date: 2025-01-22
Form Type: 20-F
Source: 0001213900-25-005490
Chunk: 218

Company: Clearmind Medicine Inc.
Filing Date: 2025-01-22
Form: 20-F
Item: Item 10
Chunk 218
---
-F containing financial statements audited by an independent registered public accounting firm, and may submit to the SEC,
on a Form 6-K, unaudited quarterly financial information.

I. Subsidiary Information.

Not applicable.

ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET
RISK

Quantitative and Qualitative Disclosures about Market Risk

Liquidity Risk

Liquidity risk is the risk that we will encounter
difficulty in meeting the obligations associated with our financial liabilities that are settled in cash. Cash flow forecasting is performed
in our operating entities and aggregated at a consolidated level. We monitor forecasts of our liquidity requirements to ensure we have
sufficient cash to meet operational needs. The Company has long term liabilities as of October 31, 2024 of $16,416, we entered into an
office lease agreement in Israel commits us to $3,400 per month until March 31, 2026. We remain reliant on our ability to raise additional
investment capital from the issuance of both debt and equity securities to fund our business operating plans and future obligations.

Credit risk

Financial instruments that potentially subject
the Company to a concentration of credit risk consist primarily of cash and cash equivalents and receivables. The Company limits its
exposure to credit loss by placing its cash with high credit quality financial institutions. The carrying amount of financial assets
represents the maximum credit exposure.

Credit risk is the risk of financial loss to us
if a debtor or counterparty to a financial instrument fails to meet its contractual obligations, and arises mainly from our receivables.

We restrict exposure to credit risk in the course
of our operations by investing only in bank deposits.

Equity price risk

As we do not have material investments in securities
riskier than short-term bank deposits, we do not believe that changes in equity prices pose a material risk to our holdings. However,
decreases in the market price of our Common Shares could make it more difficult for us to raise additional funds in the future or require
us to raise funds at terms unfavorable to us.

Inflation risk

We do not believe that inflation has had a material
effect on our business, financial condition or results of operations in the reporting period. If our costs were to become subject to
significant inflationary pressures, we may not be able to fully offset such higher costs through hedging transactions. Our inability
or failure to do so could harm our business, financial condition and results of operations.